Recherche avancée
Affichage des résultats 5841 à 5860 sur 7197 au total
-
CopyMean: A new method to predict monotone missing values in longitudinal studies
C. Genolini, A. Lacombe, R. Ecochard, F. Subtil
-
Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality
O. Boussari, F. Subtil, C. Genolini, M. Bastard, J. Iwaz, N. Fonton, Jf. Etard, René Ecochard
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trial
Pierre-Yves Meunier, Camille Raynaud, Emmanuelle Guimaraes, François Gueyffier, Laurent Letrilliart
-
Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia
Catherine Cornu, Anne Donche, Carine Coffre, Amélie Le Gouge, Boulkedid Rym, Isabelle Vaugier, Frédéric Barbot, Alain Leizorovicz, Nadine Juge, Céline Giraud, François Gueyffier, Alexandra Félin, Thibault Mura, Hugues Chevassus, Christine Binquet
-
Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug
N. Eymard, N. Bessonov, V. Volpert, P. Kurbatova, F. Gueyffier, P. Nony
-
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
G. Grenet, H. H. Le, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, B. Kassai, P. Moulin, F. Gueyffier, M. Cucherat
-
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
G. Grenet, S. Ribault, G. B. Nguyen, F. Glais, A. Metge, T. Linet, B. Kassai-Koupai, C. Cornu, T. Bejan-Angoulvant, S. Erpeldinger, R. Boussageon, A. Gouraud, F. Bonnet, M. Cucherat, P. Moulin, F. Gueyffier
-
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
S. Erpeldinger, M. B. Rehman, C. Berkhout, C. Pigache, Y. Zerbib, F. Regnault, E. Guerin, I. Supper, Catherine Cornu, B. Kassai, F. Gueyffier, R. Boussageon
-
Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial
F. Gueyffier, F. Subtil, T. Bejan-Angoulvant, Y. Zerbib, J. P. Baguet, J. M. Boivin, A. Mercier, G. Leftheriotis, J. P. Gagnol, J. P. Fauvel, C. Giraud, G. Bricca, Delphine Maucort-Boulch, S. Erpeldinger
-
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in children
Perrine Janiaud, A. Lajoinie, F. Cour-Andlauer, Catherine Cornu, P. Cochat, Michel Cucherat, F. Gueyffier, B. Kassai
-
The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
Laurence Lion-François, François Gueyffier, Catherine Mercier, Daniel Gérard, Vania Herbillon, Isabelle Kemlin, Diana Rodriguez, Tiphanie Ginhoux, Emeline Peyric, Virginie Coutinho, Valentine Bréant, Vincent Des Portes, Stéphane Pinson, Patrick Combemale, Behrouz Kassai
-
L\textquoterighteffet placebo chez l\textquoterightenfant est méconnu et peu étudié
B. Kassai, H. Gheit, R. Boussageon, F. Gueyffier
-
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Rémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, Nadir Kellou, Michel Cucherat, Jean-Pierre Boissel, Behrouz Kassai, Moreau Alain, François Gueyffier, Catherine Cornu
-
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, Behrouz Kassai, S. Erpeldinger, Jm. Wright, François Gueyffier, Catherine Cornu
-
Recueil systématique et actif des evènements indésirables médicamenteux chez les enfants admis aux urgences pédiatriques
F. Planchamp, K.-A. Nguyen, T. Vial, S. Nasri, E. Javouhey, Y. Gillet, B. Ranchin, F. Villard, D. Floret, P. Cochat, François Gueyffier, Behrouz Kassai
-
Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data
Behrouz Kassai, C. Chiron, S. Augier, Michel Cucherat, E. Rey, François Gueyffier, R. Guerrini, J. Vincent, O. Dulac, Gérard Pons
-
Critères intermédiaires et critères de substitution
Behrouz Kassai, François Gueyffier, J-P. Boissel
-
Safety of computerized drug management: a case report
K.-A. Nguyen, T. Vial, François Gueyffier, S. Marignier, P. Cochat, Behrouz Kassai
-
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests
Behrouz Kassai, N.R. Shah, A. Leizorovicz, Michel Cucherat, François Gueyffier, J.-P. Boissel
-
Absolute benefit number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?
Behrouz Kassai, François Gueyffier, J.-P. Boissel, F. Boutitie, Michel Cucherat